CD44 and cancer: These data, in conjunction with the high expression levels of ESRP1 in PC3-Epi and lack of expression in PC3-EMT, suggested that the alternative splice forms of CD44 may be of interest in differentiating between epithelial and mesenchymal cancer cells.